The US Food and Drug Administration (FDA) on Friday outlined a set of proposed reforms to advance modern manufacturing ...
As Food Safety Expectations Continue to Evolve, Synexis® LLC and IXOM are Helping Food and Dairy Processors Explore New ...
A single-registration pathway would allow distributed networks to add, remove, or relocate units with less administrative complexity while maintaining centralized quality oversight and improved FDA ...
What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...
Companies invest in smart manufacturing technology, the technology works, yet the operational results still disappoint.
China Penicillin G Acylase Market Snapshot. The China penicillin G acylase (PGA) market was valued at USD 25.05 million in 2025 and is forecast to reach USD 49.42 million by 2035, ...
KushoAI Introduces API Testing Maturity Model to Help Enterprises Navigate the Next Phase of AI-Driven Software Development ...
Opinion
16don MSNOpinion
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME Day
Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry representatives urge policy reforms, including energy access and ...
TOKYO--(BUSINESS WIRE)--Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) ...
Industry associations have urged the government to make effective use of the substantial unutilised capacity available with domestic Active Pharmaceutical Ingredient (API) manufacturers. This, ...
The modern pharmaceutical landscape is undergoing rapid transformation. Whether dealing with small molecules, complex biologics, or hybrid modalities, active pharmaceutical ingredient (API) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results